Collectively, these data are consistent with the hypothesis that arginase-1 producing TAMs present in the tumor microenvironment induce local, but not systemic, suppression of anti-tumor immunity following injection of MCA-205-OVA tumor cells. Here, ARG1 is linked to neoplasm.